In patients with Osteoarthritis of the hip undergoing a Total Hip Replacement, how does the MASTER-SL femoral stem perform under standard conditions with regards to clinical outcomes.

The Orthopaedic Institute of Queensland (ORIQL)0 个研究点目标入组 50 人开始时间: 2017年4月19日最近更新: 2021年10月11日

适应症

试验速览

暂无简介。

•Male and female >18 years;
•radiologically confirmed diagnosis of primary osteoarthritis (OS) of the hip and suitable for primary total hip replacement;
•Life expectancy of > 10 years
•Receiving a MASTER-SL femoral stem
•Voluntary written informed consent obtained

•Prospect for recovery to independent mobility compromised by known coexistent, medical problems;
•Requiring revision hip replacement;
•Loss of abductor musculature, poor bone stock, or poor skin coverage around the hip join;
•Previous organ transplant;
•Previous hip replacement (resurfacing or THR) on the contra-lateral side within the last 6 months;
•Previous hip replacement (resurfacing or THR) on the contralateral side and whose outcome is achieving an Oxford Hip score <18 points;
•Body mass index > 40 kg/m2
•Active or suspected infection;
•Known sensitivity to device materials;
•Pregnant woman

发起方

The Orthopaedic Institute of Queensland (ORIQL)